Faculty Directory

Back to Search Results
 
Muralidharan Jagadeesan Muralidharan Jagadeesan
Associate Professor of Medicine

Office Phone: 202-741-2238
Email: Email
Department: Medicine

Education

  • M.B.B.S, Madras Medical College,Madras University,India, 1986

Biography

Dr. Muralidharan Jagadeesan is an associate professor of medicine in the Division of Renal Diseases and Hypertension and the Chairman of Transplant Medicine at the George Washington University (GW) School of Medicine and Health Sciences and the GW Medical Faculty Associates. He also is the Medical Director of the Renal Transplant Program at the George Washington University Hospital.

Prior to joining George Washington University, Dr. Jagadeesan was an associate professor of medicine, in the Division of Nephrology at the Medical College of Georgia. He also was the program director of the Transplant Nephrology Fellowship program there. Additionally, Dr. Jagadeesan was a member of several committees, including the Institutional Review Board. He is a Fellow of the American College of Physicians as well as a Fellow of the American Society of Nephrology.

Training:

  • Residency:
    Internal Medicine, Woodhull Medical Center (SUNY-Brooklyn) 1990 - 1993
  • Fellowships:
    Nephrology, University of Toronto, 1993-1995
    Transplant nephrology, University of Toronto, 1996-1997

Clinical Service:

  • Transplant Nephrology
  • General Nephrology

Expertise:

  • Pre-transplant Evaluations
  • Post-transplant Care
  • Novel immunosuppression
  • Across the blood group transplantation
  • Transplantation in HIV patients
  • Post-transplant Infections
  • Post-transplant malignancies

Research

  • Provided Care in an Indigent Care Clinic in Augusta GA for last 5 years
  • Education of patients with Kidney Disease through meetings and presentations in the DC area

Division

  • Renal Diseases and Hypertension

Publications

View publications by this faculty member from January 1, 2013 - present

Raj Dominic, Jagadeesan Muralidharan, Aminrazavi et al. . Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney disease among Patients with Chronic Kidney Disease – CJASN, 2015 (In press)

Horuzko, Kapoor, Jagadeesan, Mulloy et al. HLA dimers in prolongation of Kidney Allograft Survival. Journal of Immunology Research, 2014

Gaber et al and the Sirolimus Study Group@ Transplantation. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. 2008 Nov 15;86(9):1187-95.

Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Coadministration of tacrolimus with anti-acid drugs. Transplantation. 2003 Aug 27;76(4):665-6.

Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Two-Year economic evaluation of clinical pharmacy services in renal transplant clinic patients. American Transplant Congress Transplant 2002, April 26 – May 1, 2002.

Chisholm MA, Mulloy LL, Jagadeesan M, Martin BC, DiPiro JT. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethnicity & Disease. 12(3):392-397, July 2002.

Paul LC, Muralidharan J, Valentin JF, Muzzafar SA. Antibodies against mesangial cells and their secretory products. American Journal of Pathology 152:1209-1223, 1998.

Paul LC, Muralidharan J, Bennediktsson H. Immunological and hemodynamic mechanisms in chronic allograft rejection. Transplantation Immunology 4(1):39-42, 1996.

Additional publications published before January 1, 2013 may be available within Himmelfarb Library's database.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • None